Systemic treatment of microRNA therapeutic targeting miR-10b inhibits breast cancer m

[News]

Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.

More... (http://www.news-medical.net/news/20100330/Systemic-treatment-of-microRNA-therapeutic-targeting-miR-10b-inhibits-breast-cancer-metastasis.aspx)